These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24810646)

  • 1. Advances in managing hepatocellular carcinoma.
    Reataza M; Imagawa DK
    Front Med; 2014 Jun; 8(2):175-89. PubMed ID: 24810646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.
    Nakamura K; Beppu T; Hayashi H; Okabe H; Imai K; Nitta H; Chikamoto A; Ishiko T; Sasaki M; Baba H
    Int Surg; 2015 May; 100(5):908-14. PubMed ID: 26011214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
    Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
    Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapies for hepatocellular carcinoma: a critical view of the evidence.
    Villanueva A; Hernandez-Gea V; Llovet JM
    Nat Rev Gastroenterol Hepatol; 2013 Jan; 10(1):34-42. PubMed ID: 23147664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.
    Cabibbo G; Tremosini S; Galati G; Mazza G; Gadaleta-Caldarola G; Lombardi G; Antonucci M; Sacco R
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):831-45. PubMed ID: 24850249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
    Yoshimoto T; Imura S; Morine Y; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Takasu C; Ishikawa D; Teraoku H; Bando Y; Shimada M
    Anticancer Res; 2018 Jan; 38(1):501-507. PubMed ID: 29277815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
    Raza A; Sood GK
    World J Gastroenterol; 2014 Apr; 20(15):4115-27. PubMed ID: 24764650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy of hepatocellular carcinoma: current and promising.
    Kalyan A; Nimeiri H; Kulik L
    Clin Liver Dis; 2015 May; 19(2):421-32. PubMed ID: 25921671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.
    Cabibbo G; Petta S; Maida M; Cammà C
    Dig Dis; 2015 Sep; 33(5):668-74. PubMed ID: 26398633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete Regression of Recurrent Advanced Hepatocellular Carcinoma After Liver Transplantation in Response to Sorafenib Treatment: A Case Report.
    Lee HY; Yang KH; Choi BH; Park YM; Yoon KT; Ryu JH; Chu CW
    Transplant Proc; 2016; 48(1):247-50. PubMed ID: 26915876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
    Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
    Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplantation After Neoadjuvant Sorafenib Therapy: Preliminary Experience and Literature Review.
    Golse N; Radenne S; Rode A; Ducerf C; Mabrut JY; Merle P
    Exp Clin Transplant; 2018 Apr; 16(2):227-236. PubMed ID: 27212671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
    Qi X; Zhao Y; Li H; Guo X; Han G
    Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?
    Cabibbo G; Maida M; Cammà C; Craxì A
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1355-61. PubMed ID: 24224926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of long-term survivors following sorafenib treatment for advanced hepatocellular carcinoma: report of a workshop at the 50th Annual Meeting of the Liver Cancer Study Group of Japan.
    Tanaka K; Shimada M; Kudo M
    Oncology; 2014; 87 Suppl 1():104-9. PubMed ID: 25427741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma.
    Huan HB; Lau WY; Xia F; Ma KS; Bie P
    World J Gastroenterol; 2014 Oct; 20(39):14505-9. PubMed ID: 25339839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.